ReNetX Bio, Inc
157 Church Street, 19th Floor
New Haven, CT 06510
ReNetX Bio is changing lives through the REstoration of neural NETworks. Our mission is to provide first-in-class therapeutics to treat injury/damage to the central nervous system (CNS) in conditions such as spinal cord injury (SCI), stroke, and glaucoma.
The company was founded based on the innovative technology from Dr. Stephen Strittmatter’s work at Yale University to improve neurologic function after CNS injury – creating a significant and completely unmet need estimated at >$5B annually. The technology allows neurons to regrow by eliminating factors that inhibit growth.
This technology platform could help to restore function in patients who are suffering from spinal cord injuries, stroke and glaucoma.